| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |